These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 16450683)

  • 1. Systemic ototoxicity: a review.
    Shine NP; Coates H
    East Afr Med J; 2005 Oct; 82(10):536-9. PubMed ID: 16450683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ototoxicity induced by gentamicin and furosemide.
    Bates DE; Beaumont SJ; Baylis BW
    Ann Pharmacother; 2002 Mar; 36(3):446-51. PubMed ID: 11895059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding drug ototoxicity: molecular insights for prevention and clinical management.
    Yorgason JG; Fayad JN; Kalinec F
    Expert Opin Drug Saf; 2006 May; 5(3):383-99. PubMed ID: 16610968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of ototoxicity in a Nigerian teaching hospital.
    Salisu AD; Hasheem MG
    Niger J Med; 2010; 19(3):320-3. PubMed ID: 20845639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of furosemide ototoxicity.
    Rybak LP
    J Otolaryngol; 1982 Apr; 11(2):127-33. PubMed ID: 7042998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
    Hong H; Dooley KE; Starbird LE; Francis HW; Farley JE
    Arch Toxicol; 2019 May; 93(5):1385-1399. PubMed ID: 30963202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced hearing loss as a manifestation of drug-induced ototoxicity].
    Ostroumova OD; Chikh EV; Rebrova EV; Ryazanova AY; Pereverzev AP
    Vestn Otorinolaringol; 2019; 84(4):72-80. PubMed ID: 31579063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum.
    Koegel L
    Am J Otol; 1985 Mar; 6(2):190-9. PubMed ID: 3872601
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ototoxic drugs. I. Aminoglycoside antibiotics].
    Buszman E; Wrześniok D; Matusiński B
    Wiad Lek; 2003; 56(5-6):254-9. PubMed ID: 14526485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs ].
    Wrześniok D; Buszman E; Matusiński B
    Wiad Lek; 2003; 56(7-8):369-74. PubMed ID: 14969167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity: etiology and issues.
    D'Alonzo BJ; Cantor AB
    J Fam Pract; 1983 Mar; 16(3):489-94. PubMed ID: 6338150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility to aminoglycoside ototoxicity.
    Nguyen T; Jeyakumar A
    Int J Pediatr Otorhinolaryngol; 2019 May; 120():15-19. PubMed ID: 30743189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.
    Hong H; Budhathoki C; Farley JE
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):667-674. PubMed ID: 29862952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced tinnitus and other hearing disorders.
    Seligmann H; Podoshin L; Ben-David J; Fradis M; Goldsher M
    Drug Saf; 1996 Mar; 14(3):198-212. PubMed ID: 8934581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside-induced ototoxicity.
    Selimoglu E
    Curr Pharm Des; 2007; 13(1):119-26. PubMed ID: 17266591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting.
    Harris T; Peer S; Fagan JJ
    J Laryngol Otol; 2012 Jun; 126(6):548-51. PubMed ID: 22459550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.
    Garinis AC; Poling GL; Rubenstein RC; Konrad-Martin D; Hullar TE; Baguley DM; Burrows HL; Chisholm JA; Custer A; Hawe LD; Hunter LL; Marras TK; Ortiz CE; Petersen L; Steyger PS; Winthrop K; Zettner EM; Clark K; Hungerford M; Vachhani JJ; Brewer CC
    Am J Audiol; 2021 Oct; 30(3S):800-809. PubMed ID: 34549989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin C alleviates ototoxic effect caused by coadministration of amikacin and furosemide.
    Zadrozniak M; Szymanski M; Luszczki JJ
    Pharmacol Rep; 2019 Apr; 71(2):351-356. PubMed ID: 30831441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Substance Misuse on Auditory and Vestibular Function: A Systematic Review.
    Chiao A; Hughes ML; Karimuddanahalli Premkumar P; Zoucha K
    Ear Hear; 2024 Mar-Apr 01; 45(2):276-296. PubMed ID: 37784231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.